These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15867211

  • 1. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frère Belda MA, Lecuru F, Mayi TH, Mazure N, Favaudon V, Massaad C, Barouki R, Massaad-Massade L.
    Cancer Res; 2008 Apr 01; 68(7):2158-65. PubMed ID: 18381421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM, Bulun SE.
    Cancer Res; 2001 Mar 01; 61(5):2250-5. PubMed ID: 11280794
    [Abstract] [Full Text] [Related]

  • 5. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 11. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC.
    Cancer Res; 2005 Feb 01; 65(3):861-7. PubMed ID: 15705884
    [Abstract] [Full Text] [Related]

  • 12. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R, Hanf V, Emons G, Gründker C.
    J Pineal Res; 2009 Aug 01; 47(1):23-31. PubMed ID: 19522736
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
    Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi K.
    Cancer Res; 2007 Dec 01; 67(23):11272-83. PubMed ID: 18056453
    [Abstract] [Full Text] [Related]

  • 14. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M.
    Cancer Res; 2003 Sep 15; 63(18):5926-39. PubMed ID: 14522919
    [Abstract] [Full Text] [Related]

  • 15. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V.
    Biochem Pharmacol; 2007 Feb 15; 73(4):491-503. PubMed ID: 17126818
    [Abstract] [Full Text] [Related]

  • 16. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
    Blagosklonny MV, Prabhu NS, El-Deiry WS.
    Cancer Res; 1997 Jan 15; 57(2):320-5. PubMed ID: 9000576
    [Abstract] [Full Text] [Related]

  • 17. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
    Montanari M, Boninsegna A, Faraglia B, Coco C, Giordano A, Cittadini A, Sgambato A.
    J Cell Physiol; 2005 Jan 15; 202(1):215-22. PubMed ID: 15389519
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 20. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.
    Hu Y, Davies GE.
    Phytomedicine; 2009 Sep 01; 16(9):864-73. PubMed ID: 19403287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.